TNF‐α blockers for the treatment of Kawasaki disease in children
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"TNF‐α Blockers for the Treatment of Kawasaki Disease in Children." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432957/all/TNF‐α_blockers_for_the_treatment_of_Kawasaki_disease_in_children.
TNF‐α blockers for the treatment of Kawasaki disease in children. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432957/all/TNF‐α_blockers_for_the_treatment_of_Kawasaki_disease_in_children. Accessed February 12, 2025.
TNF‐α blockers for the treatment of Kawasaki disease in children. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432957/all/TNF‐α_blockers_for_the_treatment_of_Kawasaki_disease_in_children
TNF‐α Blockers for the Treatment of Kawasaki Disease in Children [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432957/all/TNF‐α_blockers_for_the_treatment_of_Kawasaki_disease_in_children.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - TNF‐α blockers for the treatment of Kawasaki disease in children
ID - 432957
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432957/all/TNF‐α_blockers_for_the_treatment_of_Kawasaki_disease_in_children
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -